日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A novel inhibitor of soluble epoxide hydrolase that adducts C521 is cardioprotective

一种新型可溶性环氧化物水解酶抑制剂,可与C521加合,具有心脏保护作用

Charles, Rebecca L; Fernandez-Caggiano, Mariana; Rudyk, Olena; Tyson-Hirst, Izaak; Ehteramyan, Mazdak; Switzer, Christopher H; Buccafusca, Roberto; Rajeeve, Vinothini; Bianchi, Katiuscia; Morales, Valle; Finch, Andrew J; Eaton, Philip

IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM

IMS-IMWG 2025共识基因组分期可预测基于达雷妥尤单抗的四联疗法治疗新诊断多发性骨髓瘤的疗效。

Maclachlan, Kylee H; Tan, Carlyn R; Shekarkhand, Tala; Rueda, Colin; Derkach, Andriy; Hashmi, Hamza; Hassoun, Hani; Shah, Urvi A; Hultcrantz, Malin; Lesokhin, Alexander M; Mailankody, Sham; Maura, Francesco; Merz, Maximillian; Firestone, Ross; Jurgens, Eric M; Miller, Kevin C; Rajeeve, Sridevi; Giralt, Sergio; Shah, Gunjan L; Scordo, Michael; Landau, Heather J; Zhang, Yanming; Cimera, Robert; Arcila, Maria E; Korde, Neha; Usmani, Saad Z

Long-term remission after cilta-cel in multiple myeloma is linked to diverse T cells and low myeloid suppression

多发性骨髓瘤患者接受cilta-cel治疗后长期缓解与T细胞多样性和低髓系抑制有关。

Vieira Dos Santos, Junia; Melnekoff, David T; Aleman, Adolfo; Mouhieddine, Tarek H; Montes de Oca, Rocio; Wang, Feng; Rajeeve, Sridevi; Bhalla, Sherry; Van Oekelen, Oliver; Upadhyaya, Bhaskar; Ghodke-Puranik, Yogita; Leshchenko, Violetta; Kim-Schulze, Seunghee; Rahman, Adeeb; Afik, Shaked; Lewinsky, Hadas; Plaks, Vicki; Thibaud, Santiago; Cho, Hearn Jay; Richter, Joshua; Rodriguez, Cesar; Sanchez, Larysa; Rossi, Adriana; Richard, Shambavi; Chari, Ajai; Madduri, Deepu; Jagannath, Sundar; Parekh, Samir; Laganà, Alessandro

The Src inhibitor peptide TAT-Cx43(266-283) improves survival in an intracranial murine model of lung cancer brain metastasis

Src抑制肽TAT-Cx43(266-283)可提高肺癌脑转移小鼠颅内模型的生存率

Cerveró-García, Pilar; Jiménez-Madrona, Enrique; Álvarez-Vázquez, Andrea; Flores-Hernández, Raquel; García-Vicente, Laura; García-Guerrero, Laura; Alonso-Amador, Juan José; González-Sánchez, Raúl; Ollauri-Ibáñez, Claudia; Paniagua-Sancho, María; Talaverón, Rocío; Rodrigues-Teixeira, Telmo; Martín-Guerrero, Sandra M; Casado, Pedro; Rajeeve, Vinothini; Shields, Tommy; Hijazi, Maruan; Cutillas, Pedro R; Jaraíz-Rodríguez, Myriam; Tabernero, Arantxa

T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

T-ICAHT:CAR-T细胞治疗后血小板减少症的分级和预后影响

Rejeski, Kai; Sanz, Jaime; Fei, Teng; Nair, Monica S; Hashmi, Hamza; Avigdor, Abraham; Beyar-Katz, Ofrat; Bücklein, Veit L; Curran, Kevin J; Einarsdottir, Sigrun; Esensten, Jonathan H; Glaubach, Netta; Golan-Accav, Noa; Gomez-Llobell, Marina; Halamis, Iris; Itzhaki, Orit; Locke, Frederick L; Mailankody, Sham; Marcus, Ronit; Maus, Marcela V; Palomba, M Lia; Park, Jae H; Pasquini, Marcelo; Raj, Sandeep; Rajeeve, Sridevi; Salles, Gilles; Scordo, Michael; Shah, Gunjan L; Shimoni, Avichai; Subklewe, Marion; Tix, Tobias; Usmani, Saad Z; Valid, Ori; Valtis, Yannis K; Zuckerman, Tsila; Shah, Nirali N; Perales, Miguel-Angel; Shouval, Roni

Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

达雷妥尤单抗耐药性对复发难治性多发性骨髓瘤CAR-T细胞疗法后临床结局的影响

Sebastian, Tara; Rajeeve, Sridevi; Farzana, Tasmin; Firestone, Ross; Jurgens, Eric; Miller, Kevin; Costa, Bruno Almeida; Lesokhin, Alexander; Tan, Carlyn Rose; Shah, Gunjan; Korde, Neha; Landau, Heather; Scordo, Michael; Hassoun, Hani; Maclachlan, Kylee; Shah, Urvi; Hultcrantz, Malin; Derkach, Andriy; Nemirovsky, David; Giralt, Sergio; Usmani, Saad; Mailankody, Sham; Hashmi, Hamza

Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

更正:达雷妥尤单抗耐药性对复发难治性多发性骨髓瘤CAR-T细胞疗法后临床结局的影响

Sebastian, Tara; Rajeeve, Sridevi; Farzana, Tasmin; Firestone, Ross; Jurgens, Eric; Miller, Kevin; Costa, Bruno Almeida; Lesokhin, Alexander; Tan, Carlyn Rose; Shah, Gunjan; Korde, Neha; Landau, Heather; Scordo, Michael; Hassoun, Hani; Maclachlan, Kylee; Shah, Urvi; Hultcrantz, Malin; Derkach, Andriy; Nemirovsky, Derkach; Giralt, Sergio; Usmani, Saad; Mailankody, Sham; Hashmi, Hamza

Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma

复发/难治性多发性骨髓瘤双特异性抗体治疗期间巨细胞病毒再激活

Jurgens, Eric; Shekarkhand, Tala; Rueda, Colin; Nemirovsky, David; Derkach, Andriy; Firestone, Ross S; Miller, Kevin; Costa, Bruno Almeida; Rajeeve, Sridevi; Lesokhin, Alexander M; Korde, Neha; Tan, Carlyn R; Hashmi, Hamza; Hassoun, Hani; Maclachlan, Kylee; Shah, Urvi A; Hultcrantz, Malin; Hamadeh, Issam; Giralt, Sergio A; Shah, Gunjan L; Landau, Heather J; Scordo, Michael; Usmani, Saad Z; Mailankody, Sham; Shahid, Zainab

SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2

SFX-01 是一种治疗由 Shp2 基因激活突变引起的骨髓增生性疾病的药物。

Hyun-Ju Cho # ,Joy Smith # ,Christopher H Switzer # ,Eleni Louka ,Rebecca L Charles ,Oleksandra Prysyazhna ,Ewald Schroder ,Mariana Fernandez-Caggiano ,Daniel Simoes de Jesus ,Seda Eminaga ,Xiaoke Yin ,Xiaoping Yang ,Steven Lynham ,Manuel Mayr ,Valle Morales ,Katiuscia Bianchi ,Vinothini Rajeeve ,Pedro R Cutillas ,Adam J Mead ,Philip Eaton

Phosphoproteomics identifies determinants of PAK inhibitor sensitivity in leukaemia cells.

磷酸化蛋白质组学鉴定白血病细胞中 PAK 抑制剂敏感性的决定因素

Casado Pedro, Marfa Santiago, Hadi Marym M, Gerdes Henry, Martin-Guerrero Sandra M, Miraki-Moud Farideh, Rajeeve Vinothini, Cutillas Pedro R